You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Medicamen Biotech Ltd"

Medicamen Biotech Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report

  • 25/09/2021
  • |
  • bse

Medicamen Biotech Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM

  • 25/09/2021
  • |
  • bse

Medicamen Biotech Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 15/09/2021
  • |
  • bse

Medicamen Biotech Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 06/09/2021
  • |
  • bse

Medicamen Biotech Ltd Reg. 34 (1) Annual Report

  • 02/09/2021
  • |
  • bse

Medicamen Biotech Ltd Fixes Book Closure for Dividend & AGM (Cut-off date for e-voting)

  • 17/08/2021
  • |
  • bse

Medicamen Biotech Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 16/08/2021
  • |
  • bse

Medicamen Biotech Ltd Revised Financial Results For The Quarter Ended On June 30 2021

  • 13/08/2021
  • |
  • bse

Medicamen Biotech Ltd Financial Results For Quarter Ended June 30 2021

  • 13/08/2021
  • |
  • bse

Medicamen Biotech Ltd Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Standalone A

  • 06/08/2021
  • |
  • bse

Medicamen Biotech Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 29/07/2021
  • |
  • bse

Medicamen Biotech Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 27/07/2021
  • |
  • bse

Medicamen Biotech Ltd Shareholding for the Period Ended June 30 2021

  • 19/07/2021
  • |
  • bse

Medicamen Biotech Ltd Statement Of Investor Complaints For The Quarter Ended June 2021

  • 15/07/2021
  • |
  • bse

Medicamen Biotech Ltd Closure of Trading Window

  • 30/06/2021
  • |
  • bse

Medicamen Biotech Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 30/06/2021
  • |
  • bse

Medicamen Biotech Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 28/06/2021
  • |
  • bse

Medicamen Biotech Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations A

  • 26/06/2021
  • |
  • bse

Medicamen Biotech Ltd Board recommends Final Dividend

  • 26/06/2021
  • |
  • bse

Medicamen Biotech Ltd Standalone And Consolidated Audited Financial Results For The Quarter / Year Ended March 31 2021

  • 26/06/2021
  • |
  • bse
.